World news
Developments in hair loss and hair transplantation. We write each item with its source, saying how much evidence stands behind it and what is not yet known.
-
World news
FDA warning letters on unapproved exosome and umbilical cord products
Since December 2024, the US Food and Drug Administration (FDA) has sent warning letters to some companies marketing unapproved exosome and umbilical cord-derived products. We explain what the letters say, what they do not show, and what they mean if you are considering a hair transplant or treatment.
-
World news
Finasteride and mood: the 2025 warnings from European and US drug regulators
In May 2025, the safety committee of the European Medicines Agency recognized suicidal thoughts as a side effect of finasteride tablets. In the US, the FDA issued a warning in April 2025 about custom-made finasteride products applied to the scalp.
-
World news
Illegal hair transplant warning: what does the ISHRS 2025 member survey show?
According to a member survey published in May 2025 by the International Society of Hair Restoration Surgery (ISHRS), the share of member physicians who report illegal hair transplant providers in their city has risen. We explain the limits of these figures and what you can ask before a procedure.
-
World news
Sugar gel, fatty acids and hair follicle organoids: early-stage research on hair loss
Between 2024 and 2026, three early-stage studies on hair loss made the news. All three are at the animal or laboratory stage. We explain what was found, how strong the evidence is and how you can read news stories like these.
-
World news
Turkey’s regulation on hair transplant units changed in September 2025: what is new?
On 12 September 2025, the Ministry of Health amended the regulation that governs how hair transplant units are opened, how they operate and how they are inspected. We explain what has changed, what is not yet clear and what it means for patients.
-
World news
JAK inhibitors for alopecia areata: developments in 2024–2026
Since July 2024, oral JAK inhibitors have received new approvals for severe alopecia areata, and the results of long-term and phase 3 studies have been published. We explain what has happened, how strong the evidence is and what it means if you are considering a hair transplant.
-
World news
Turkey’s 2025 health tourism regulation: what has changed for patients coming from abroad?
The rules for facilities that serve patients who come to Turkey from abroad for treatment were redefined by a new regulation published on 26 April 2025. We explain the main changes, and the points we could not verify, in plain language.
-
World news
Drug candidates under study for male pattern hair loss: clascoterone and pyrilutamide
Clascoterone and pyrilutamide are two drug candidates for male pattern hair loss that are applied to the scalp. The companies developing them have announced phase 3 results; neither is approved for hair loss. We explain what is known, what is not known and the situation in Turkey.
Hair analysis
Leave your name and phone number, and we will get back to you by phone or on WhatsApp. We do not ask for health information or photos in this form.
What happens next?
- We contact you by phone or on WhatsApp to arrange a preliminary consultation at a time that suits you.
- In the consultation, we listen to your expectations and explain the procedure and the process. If photos are needed, we tell you separately how to share them.
- Whether a procedure is suitable for you is decided at the doctor's examination. Fees and dates are discussed after planning.